-
Scale-up of integrated HIV services had reached the following number of sites:
-
724 static (579 within, 145 outside of health facilities) and 188 outreach HTC sites
-
732 (static) ART sites; 626 of these had started at least one pregnant or breastfeeding woman this quarter
-
670 sites with patients in pre-ART follow-up
-
671 sites with HIV-exposed children in follow-up
-
876,337 persons were tested for HIV and received their results; 267,166 (30%) accessed HIV testing for the first time; 609,171 (70%) were repeat testers and 38,270 (6%) of these received confirmatory testing (after having tested positive in the past). 39,176 (5%) clients received a positive result for the first time.
-
24,767 (96 %) of 25,755 blood units collected were screened for (at least) HIV, hepatitis B and syphilis.
-
140,475 (95%) of 148,513 women at ANC had their HIV status ascertained; 11,017 (8%) of these were HIV positive. 119,717 (98%) of 121,610 women at maternity had their HIV status ascertained 8,706 (8%)_ of these were HIV positive.
-
28,657 patients started ART this quarter.
-
631,169 patients were alive and on ART by end of June 2016. This means that 64% of the estimated 979,000 HIV positive population was on ART. 1 ART coverage was 63% (50,947 / 81,000) for children2 and 65% (580,222 / 898,000) for adults.
-
77% of adults and 75% of children were retained alive on ART at 12 months after initiation. Actual retention rates are thought to be about 10% higher due to misclassification of ‘silent transfers’ as defaulters in clinic-based survival/retention analysis. (see section 15.4)
-
548,195 (93%) of 590,827 patients on first line adult ART were on regimen 5A (TDF/3TC/EFV).
-
11,155 3 (83%) of an estimated 13,500 HIV infected pregnant women in Malawi were on ART this quarter. 6,514 (58%) of these were already on ART when getting pregnant and 4,641 (42%) started ART during pregnancy/delivery.
-
An additional 1,715 breastfeeding women started ART due to Option B+ (in WHO stage 1/2)
-
77%, 71%, 68% and 66% of women started under Option B+ were retained on ART at 6, 12, 24 and 36 months after initiation, respectively.
-
8,259 (7%) of infants discharged alive from maternity were known to be HIV exposed, 7,728 (94%) of these received ARV prophylaxis (nevirapine). 7,708 (99%) were enrolled in exposed child follow-up before age 2 months.
-
11,805 HIV exposed children and 6,632 pre-ART patients were enrolled for follow-up in HIV Care Clinics (HCC) during this quarter.
